Get started
GlaxoSmithKline Pharmaceuticals LimitedGlaxoSmithKline Pharmaceuticals LimitedGlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with GlaxoSmithKline Pharmaceuticals Limited



Key stats


Market capitalization
‪455.55 B‬ INR
Dividend yield (indicated)
2.12%
Price to earnings Ratio (TTM)
42.3
Basic EPS (TTM)
63.1 INR
Net income (FY)
‪10.36 B‬ INR
Revenue (FY)
‪38.22 B‬ INR
Shares float
‪41.26 M‬
Beta (1Y)
0.73

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪3.1 K‬
Change (1Y)
−10−0.32%
Revenue / Employee (1Y)
‪12.32 M‬ INR
Net income / Employee (1Y)
‪3.34 M‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Bhushan Akshikar
Website
gsk-india.com
Headquarters
Mumbai
Founded
1924
IPO date
Nov 3, 1994
ISIN
INE159A01016
FIGI
BBG000CRN7T4
Identifiers
ISIN INE159A01016
CFI code
ESVUFN
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


SMIN
Ishares MSCI India Small Cap ETF
Weight0.30%
Market value‪2.27 M‬
EMGF
iShares Emerging Markets Equity Factor ETF
Weight0.12%
Market value‪2.20 M‬
FID
Franklin FTSE India Index ETF Trust Units
Weight0.07%
Market value‪1.89 M‬
FLIN
Franklin FTSE India ETF
Weight0.07%
Market value‪1.89 M‬
FLXI
Franklin LibertyShares ICAV - FTSE India UCITS ETF
Weight0.07%
Market value‪1.52 M‬
MID150BEES
Nippon India ETF Nifty Midcap 150
Weight0.26%
Market value‪1.03 M‬
EPI
WisdomTree India Earnings Fund
Weight0.06%
Market value‪913.77 K‬
MIDCAPETF
Mirae Asset Nifty Midcap 150 ETF Exchange Traded Fund Units
Weight0.26%
Market value‪503.27 K‬
SPYX
State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF Accum USD
Weight0.08%
Market value‪493.87 K‬
MIDQ50ADD
DSP Nifty Midcap 150 Quality 50 ETF Units Exchange Traded Fund
Weight2.31%
Market value‪239.42 K‬
EEMS
iShares MSCI Emerging Markets Small Cap ETF
Weight0.06%
Market value‪239.31 K‬

Explore more ETFs 

Frequently asked questions


The current price of GLAXO is 2,702.9 INR — it has decreased by −0.54% in the past 24 hours. Watch GlaxoSmithKline Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GlaxoSmithKline Pharmaceuticals Limited stocks are traded under the ticker GLAXO.
GLAXO stock has risen by 3.03% compared to the previous week, the month change is a 6.71% rise, over the last year GlaxoSmithKline Pharmaceuticals Limited has showed a −2.51% decrease.
We've gathered analysts' opinions on GlaxoSmithKline Pharmaceuticals Limited future price: according to them, GLAXO price has a max estimate of 3,500.00 INR and a min estimate of 2,870.00 INR. Watch GLAXO chart and read a more detailed GlaxoSmithKline Pharmaceuticals Limited stock forecast: see what analysts think of GlaxoSmithKline Pharmaceuticals Limited and suggest that you do with its stocks.
GLAXO reached its all-time high on Jun 5, 2025 with the price of 3,515.7 INR, and its all-time low was 110.0 INR and was reached on Sep 27, 2001. View more price dynamics on GLAXO chart.
See other stocks reaching their highest and lowest prices.
GLAXO stock is 1.88% volatile and has beta coefficient of 0.73. Track GlaxoSmithKline Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is GlaxoSmithKline Pharmaceuticals Limited there?
Today GlaxoSmithKline Pharmaceuticals Limited has the market capitalization of ‪455.55 B‬, it has increased by 3.53% over the last week.
Yes, you can track GlaxoSmithKline Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
GlaxoSmithKline Pharmaceuticals Limited is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
GlaxoSmithKline Pharmaceuticals Limited revenue for the last quarter amounts to ‪9.38 B‬ INR, despite the estimated figure of ‪10.14 B‬ INR. In the next quarter, revenue is expected to reach ‪11.28 B‬ INR.
GLAXO net income for the last quarter is ‪2.37 B‬ INR, while the quarter before that showed ‪2.78 B‬ INR of net income which accounts for 0.00% change. Track more GlaxoSmithKline Pharmaceuticals Limited financial stats to get the full picture.
Yes, GLAXO dividends are paid annually. The last dividend per share was 57.00 INR. As of today, Dividend Yield (TTM)% is 2.12%. Tracking GlaxoSmithKline Pharmaceuticals Limited dividends might help you take more informed decisions.
GlaxoSmithKline Pharmaceuticals Limited dividend yield was 2.50% in 2025, and payout ratio reached 93.21%. The year before the numbers were 1.46% and 76.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 18, 2026, the company has ‪3.1 K‬ employees. See our rating of the largest employees — is GlaxoSmithKline Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GlaxoSmithKline Pharmaceuticals Limited EBITDA is ‪13.65 B‬ INR, and current EBITDA margin is 34.70%. See more stats in GlaxoSmithKline Pharmaceuticals Limited financial statements.
Like other stocks, GLAXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlaxoSmithKline Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlaxoSmithKline Pharmaceuticals Limited technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlaxoSmithKline Pharmaceuticals Limited stock shows the strong buy signal. See more of GlaxoSmithKline Pharmaceuticals Limited technicals for a more comprehensive analysis.